operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full

Page 91

consumers receiving a dose of the AstraZeneca vaccine. This Programme requirement will be regularly reviewed. This section is designed to be applicable to sites delivering the AstraZeneca COVID-19 Vaccine and provides guidance and assistance to providers, to maintain public safety and ensure consistent and equitable vaccination practices are in place across New Zealand/Aotearoa. This section should be read and interpreted alongside the Immunisation Handbook 2020, the Standards, and IMAC resources.

Appendices relevant to this section Appendix G: Vaccination site screening questions Appendix H: Supported decision-making process Appendix I: Serious Adverse Event Process (process steps, SAC examples, notification form)

Booking and scheduling Arrangements for the booking and scheduling of the AstraZeneca Vaccine can be found in the National Immunisation Booking System.

24.1 Booking second doses Do not vaccinate less than 28 days • The administration of the AstraZeneca COVID-19 Vaccine at an interval of less than 28 days is not approved by Medsafe and is considered off-label use and must be reported to CARM. • New bookings made through bookmyvaccine.nz and the COVID-19 Vaccine Whakarongorau Aotearoa 0800 28 29 26. • Doses can be booked for any time after day 28.

Version 33.0 Page 91


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Document version control

2min
pages 155-156

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 153-154

Appendix J: Risk mitigations for vaccination sites

2min
page 152

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 140-141

Appendix D: Logistics and inventory management

1min
page 139

Appendix G: Vaccination site screening questions

1min
page 143

Variations

1min
page 126

Incidents

6min
pages 121-125

National Immunisation Booking System

11min
pages 115-120

Affected persons under the Vaccinations Order

4min
pages 112-114

COVID-19 Trial Vaccinations

1min
page 111

Home vaccinations

2min
pages 109-110

Mobile vaccination team

1min
page 108

Vaccination in Hospital

1min
page 107

Vaccination and Surveillance Testing

1min
page 106

Vaccination in high-risk or screened ‘positive’ consumers

4min
pages 102-104

Third primary dose for severely immunocompromised

1min
page 105

Section E: Additional programme guidance, variations and incidents

1min
page 101

AstraZeneca Vaccine administration and observation

7min
pages 95-100

AstraZeneca Preparation of doses

2min
pages 93-94

AstraZeneca Operational phase

1min
page 92

Booking and scheduling

1min
page 91

Section D: AstraZeneca COVID-19 Vaccine

1min
page 90

Paediatric Pfizer Vaccine administration and observation

8min
pages 85-89

Paediatric Pfizer Preparation of doses

3min
pages 82-84

Pfizer Vaccine administration and observation

12min
pages 69-77

Pfizer Preparation of doses

4min
pages 66-68

Pfizer Operational phase

2min
pages 63-64

Protecting security and privacy

1min
page 62

Vaccinating consumers aged 12 to 15 years

1min
page 65

Booking and scheduling

2min
pages 60-61

Becoming a COVID-19 Vaccination site

1min
page 58

Site readiness and closure

1min
page 57

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 55-56

COVID-19 Immunisation Register

3min
pages 27-29

Logistics

1min
page 30

Vaccine storage and handling

7min
pages 37-42

Infection prevention and control (IPC

2min
pages 25-26

Preparing the vaccination workforce

7min
pages 20-24

Equipment ordering and demand planning

7min
pages 31-36

Site considerations

7min
pages 16-19

Section A: Ready to vaccinate

1min
page 13
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full by WBOP PHO - Issuu